Prognosis
The Future of Medicine May Land Within Five to 10 Years, Crispr Inventor Says
Source: KTSDESIGN/Science Photo Library via Getty Images
This article is for subscribers only.
A pioneer of the Crispr gene-editing technology that’s taken Wall Street by storm says the field is probably five to 10 years away from having an approved therapy for patients.
Biochemist Jennifer Doudna, who runs the Doudna Lab at the University of California at Berkeley, says major questions remain about the safety and effectiveness of experimental therapies that aim to disrupt or repair defective genes. But she’s optimistic about their prospects.